Plasma membrane association of cathepsin B in human prostate cancer: Biochemical and immunogold electron microscopic analysis

Prostate

Volumn 49, Issue 3, 2001, Pages 172-184

  Sinha, Akhouri A ^a,c   Jamuar, Mahendra P ^a   Wilson, Michael J ^a,b,c   Rozhin, Jurij ^d   Sloane, Bonnie F ^d  

^a UNIVERSITY OF MINNESOTA   (United States)

^b UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

^d WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Benign prostatic hyperplasia; Biochemical methods; Cathepsin B; Cysteine protease inhibitors; Immunogold electron microscopy; Isolation of lysosomes, endosomes plasma membranes; Malignant prostate; Subcellular distribution of CB; Subcellular fractionation

Indexed keywords

4 CHLOROMERCURIBENZOIC ACID; ANTIPAIN; APROTININ; CATHEPSIN B; CHYMOSTATIN; CYSTEINE PROTEINASE; CYSTEINE PROTEINASE INHIBITOR; IODOACETIC ACID; LEUPEPTIN; PEPSTATIN; PROSTATE SPECIFIC ANTIGEN; SOYBEAN TRYPSIN INHIBITOR;

ARTICLE; CANCER GRADING; CARCINOGENESIS; CELL MEMBRANE; CELL STRUCTURE; CELLULAR DISTRIBUTION; CLINICAL ARTICLE; ELECTRON MICROSCOPY; ENZYME ACTIVITY; HUMAN; HUMAN TISSUE; IMMUNOGOLD STAINING; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATE HYPERTROPHY; SCORING SYSTEM;

CATHEPSIN B; CELL MEMBRANE; CYSTEINE PROTEINASE INHIBITORS; HUMANS; IMMUNOHISTOCHEMISTRY; LYSOSOMES; MALE; MICROSCOPY, IMMUNOELECTRON; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC HYPERPLASIA; PROSTATIC NEOPLASMS; SUBCELLULAR FRACTIONS;

EID: 0035156738     PISSN: 02704137     EISSN: None     Source Type: Journal    
DOI: 10.1002/pros.1132     Document Type: Article

References (47)

1. Prognostic significance of cathepsin B and L in primary human breast cancer
2. Immunochemical analysis of cathepsin B in lung tumours: An independent prognostic factor for squamous cell carcinoma patients
3. Cathepsin B expression and its correlation with tumorassociated laminin and tumor progression in gastric cancer
4. Localization of cathepsin B in normal and hyperplastic human prostate by immunoperoxidase and protein A gold techniques
5. Plasma membrane-associated cysteine proteinases in human and animal tumors
6. Cathepsin B and its endogenous inhibitors: Role in tumor malignancy
7. Tumor cell membrane cathepsin B
8. Is altered localization of cathepsin B casually related to malignant progression?
9. Molecular regulation, membrane association and secretion of tumor cathepsin B
10. Cell producing cathepsin D, B, and L in human breast carcinoma and their association with prognosis
11. Comparative localization of cathepsin B protein and activity in colorectal cancer
12. Stage specific increase in cathepsin B messenger RNA content in human colorectal carcinoma
13. Cathepsin B expression in human tumors
14. Cathepsin B and human tumor progression
15. Cathepsin B and glioma invasion
16. Degradation of laminin by human tumor cathepsin B
17. An intracellular form of cathepsin B contributes to invasiveness in cancer
18. Degradation of extracellular-matrix proteins by human cathepsin B from normal and tumour tissues
19. The cystatins: A new class of peptidase inhibitors
20. Regulation of lysosomal endopeptidases in malignant neoplasia
21. Membrane association of cathepsin B can be induced by transfection of human breast epithelial cells with c-Ha-ras oncogene
22. Immunohistochemical localization of cathepsin B in neoplastic human prostate
23. Co-distribution of pro and mature cathepsin B forms in human prostate tumors detected by confocal and immunofluorescence microscopy
24. Individual prostate-specific antigen (PSA) forms as prostate tumor markers
25. Significance and metabolism of complexed and noncomplexed prostatate specific forms, and human glandular kallikrein 2 in clinically localized prostate cancer before and after radical prostatectomy
26. Immunoelectron microscopic localization of prostatic specific antigen in human prostate by the protein A-gold complex
27. The ultrastructural localization of prostatic specific antigen and prostatic acid phosphatase in hyperplastic and neoplastic human prostates
28. Histologic grading of prostate cancer
29. Histologic grading and clinical staging of prostatic carcinoma
30. Properties of a plasma membrane-associated cathepsin B-like cysteine proteinase in metastatic melanoma variants
31. Pericellular pH affects distribution and secretion of cathepsin B in malignant cells
32. Cathepsin B: Association with plasma membrane in metastatic tumors
33. Cathepsins B, H, and L
34. Interrelationship of active and latent secreted human cathepsin B precursors
35. Characterization of a thiol proteinase secreted by malignant human breast tumours
36. Membrane-associated cathepsin L: A role in metastasis of melanomas
37. Measurement of protein using bicinchoninic acid
38. A study of the conditions and mechanism of the diphenylamine reactionfor the colorometric estimation of deoxyribonucleic acid
39. Human tumour cathepsin B: Comparison with normal human liver cathepsin B
40. Inhibition of cysteine proteinases and dipeptidyl peptidase 1 by egg-white cystatin
41. Cathepsin B expression in colorectal carcinomas correlates with tumor progression and shortened patient survival
42. Differential localization of cysteine protease inhibitors and a target cysteine protease, cathepsin B, by immuno-confocal microscopy
43. Exocytosis of active cathepsin B, enzyme activity at pH 7.0, inhibition and molecular mass
44. Pericellular mobilization of the tissue-destructive cysteine proteinases, cathepsins B, L, and S, by human monocyte-derived macrophages
45. The ratio of cathepsin B to stefin A identifies heterogeneity within Gleason histologic scores for human prostate cancer
46. The relationship of cathepsin B and stefin A mRNA localization identifies a potentially aggressive variant of human prostate cancer within a Gleason histologic score